IP Verse

Alkermes Pharma Ireland Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Alkermes Pharma Ireland Limited

Patent Number:
EP3566696
Title:
Risperidone Sustained Release Microsphere Composition
Applicant:
GENEORA PHARMA (SHIJIAZHUANG) CO., LTD.
Opposition Date:
Jul 7, 2021
Patent Number:
EP3104844
Title:
Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them
Applicant:
DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
Opposition Date:
Nov 11, 2020
Patent Number:
EP3199146
Title:
Risperidone Sustained Release Microsphere Composition
Applicant:
NANJING LUYE PHARMACEUTICAL CO., LTD.
Opposition Date:
Apr 17, 2020
Patent Number:
EP2582697
Title:
Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them
Applicant:
DRUGGABILITY TECHNOLOGIES IP HOLDCO (JERSEY) LIMITED
Opposition Date:
Jun 27, 2018
Patent Number:
EP3010962
Title:
Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release Profile
Applicant:
PHARMATHEN S.A.
Opposition Date:
Apr 26, 2018

Latest patents of Alkermes Pharma Ireland Limited opposed by its competitors

Patent:
EP2445502
Grant Date:
Sep 28, 2022
Title:
Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders
Oppositions:
1
Patent:
EP3182958
Grant Date:
May 18, 2022
Title:
Aripiprazole Prodrug Compositions
Oppositions:
1
Patent:
EP3253377
Grant Date:
May 12, 2021
Title:
Monomethylfumarate Prodrug Compositions
Oppositions:
4
Patent:
EP2970101
Grant Date:
Jun 6, 2018
Title:
Prodrugs Of Fumarates And Their Use In Treating Various Deseases
Oppositions:
3

Competitors of Alkermes Pharma Ireland Limited

GENERICS (UK) LTD

NANJING LUYE PHARMACEUTICAL CO., LTD.

SHAN DONG LUYE PHARMACEUTICAL CO., LTD.

Want to track Alkermes Pharma Ireland Limited?

Feel free to send us a message here and we will get back to you